您的购物车当前为空
Nipamovir is a nitroimidazole prodrug that exhibits antiviral activity comparable to SAMT-247 and NS-1040 in cellular assays and a human ex vivo model of HIV infection, with low toxicity. Nipamovir has EC50 values of 3.64±3.28 and 3.23±2.81 μM for CEM-SS/HIV-1RF and hPBMC/HIV-192HT599, respectively [1].
Nipamovir is a nitroimidazole prodrug that exhibits antiviral activity comparable to SAMT-247 and NS-1040 in cellular assays and a human ex vivo model of HIV infection, with low toxicity. Nipamovir has EC50 values of 3.64±3.28 and 3.23±2.81 μM for CEM-SS/HIV-1RF and hPBMC/HIV-192HT599, respectively [1].

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 525 | 现货 | |
| 5 mg | ¥ 1,280 | 现货 | |
| 10 mg | ¥ 1,980 | 现货 | |
| 25 mg | ¥ 4,390 | 现货 | |
| 50 mg | ¥ 6,180 | 现货 | |
| 100 mg | ¥ 8,350 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,390 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Nipamovir is a nitroimidazole prodrug that exhibits antiviral activity comparable to SAMT-247 and NS-1040 in cellular assays and a human ex vivo model of HIV infection, with low toxicity. Nipamovir has EC50 values of 3.64±3.28 and 3.23±2.81 μM for CEM-SS/HIV-1RF and hPBMC/HIV-192HT599, respectively [1]. |
| 分子量 | 349.37 |
| 分子式 | C14H15N5O4S |
| CAS No. | 2651908-78-8 |
| Smiles | S(C1=C(N(=O)=O)N=CN1C)C2=C(C(NCCC(N)=O)=O)C=CC=C2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多